Genmab A/S (GMAB) Executive Team
Genmab A/S executive team at a glance
Genmab A/S lists 10 executives, led by Jan G.J. van de Winkel Ph.D., Co-Founder, President & CEO (age 64). Anthony Pagano CPA is the company's Executive VP & CFO (age 47).
In fiscal year 2025 the highest-paid executive was Jan G.J. van de Winkel Ph.D., Co-Founder, President & CEO, with total pay of $3.30 million. The 10 executives with reported pay received $12.80 million in all.
The average age of the executives with a known age is 54; the youngest is 47 and the oldest 67.
Titles, ages and pay from company filings; pay for fiscal year 2025.
Genmab A/S
Executive Team
Dr. Jan G.J. van de Winkel Ph.D.
Co-Founder, President & CEO
Mr. Anthony Pagano CPA
Executive VP & CFO
Mr. Rayne Waller
Executive VP & Chief Technical Operations Officer
Mr. Gregory David Emil Mueller
Executive VP, General Counsel & Chief Legal Officer
Mr. Christopher Cozic
Executive VP & Chief People Officer
Dr. Martine J. van Vugt Ph.D.
Executive VP & Chief Strategy Officer
Mr. Martin Schultz
Senior Director, Head of Development Business Partnership & Strategy and Director
Dr. Judith V. Klimovsky M.D.
Executive VP & Chief Development Officer
Dr. Tahamtan Ahmadi M.D., Ph.D.
Executive VP, Chief Medical Officer & Head of Experimental Medicines
Dr. Mijke Zachariasse Ph.D.
VP, Head of Antibody Research Materials & Director
Genmab A/S executive pay, fiscal year 2025
| Executive | Title | Age | Total pay |
|---|---|---|---|
| Jan G.J. van de Winkel Ph.D. | Co-Founder, President & CEO | 64 | $3.30 million |
| Rayne Waller | Executive VP & Chief Technical Operations Officer | 57 | $1.80 million |
| Gregory David Emil Mueller | Executive VP, General Counsel & Chief Legal Officer | 54 | $1.70 million |
| Judith V. Klimovsky M.D. | Executive VP & Chief Development Officer | 67 | $1.30 million |
| Tahamtan Ahmadi M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Experimental Medicines | 52 | $1.30 million |
| Anthony Pagano CPA | Executive VP & CFO | 47 | $1.10 million |
| Martine J. van Vugt Ph.D. | Executive VP & Chief Strategy Officer | 54 | $900,000 |
| Christopher Cozic | Executive VP & Chief People Officer | 47 | $800,000 |
| Martin Schultz | Senior Director, Head of Development Business Partnership & Strategy and Director | 50 | $300,000 |
| Mijke Zachariasse Ph.D. | VP, Head of Antibody Research Materials & Director | 52 | $300,000 |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
Questions and answers
Who is the CEO of Genmab A/S?
Jan G.J. van de Winkel Ph.D. (Co-Founder, President & CEO), age 64; total pay in fiscal year 2025 was $3.30 million.
Who is Genmab A/S's chief financial officer?
Anthony Pagano CPA (Executive VP & CFO), age 47.
Who is the highest-paid executive at Genmab A/S?
Jan G.J. van de Winkel Ph.D., Co-Founder, President & CEO, with total pay of $3.30 million in fiscal year 2025.
Who are Genmab A/S's top executives?
Jan G.J. van de Winkel Ph.D. (Co-Founder, President & CEO), Anthony Pagano CPA (Executive VP & CFO), Rayne Waller (Executive VP & Chief Technical Operations Officer), Gregory David Emil Mueller (Executive VP, General Counsel & Chief Legal Officer) and Christopher Cozic (Executive VP & Chief People Officer), and 5 more.
